Medinova Diagnostic Services Ltd
₹ 39.8
-0.62%
09 May
2:00 p.m.
About
Incorporated in 1985, Medinova Diagnostic Services Ltd is in the business of providing diagnostic services.
Key Points
- Market Cap ₹ 39.7 Cr.
- Current Price ₹ 39.8
- High / Low ₹ 51.0 / 32.1
- Stock P/E 44.6
- Book Value ₹ -1.19
- Dividend Yield 0.00 %
- ROCE 50.4 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of 6.58% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.59 | 7.00 | 6.45 | 6.01 | 6.68 | 6.74 | 5.49 | 11.32 | 11.51 | 7.76 | 7.78 | 7.55 | |
| 9.98 | 10.28 | 6.93 | 6.66 | 6.87 | 6.43 | 5.19 | 8.69 | 8.47 | 6.27 | 6.29 | 5.83 | |
| Operating Profit | -0.39 | -3.28 | -0.48 | -0.65 | -0.19 | 0.31 | 0.30 | 2.63 | 3.04 | 1.49 | 1.49 | 1.72 |
| OPM % | -4.07% | -46.86% | -7.44% | -10.82% | -2.84% | 4.60% | 5.46% | 23.23% | 26.41% | 19.20% | 19.15% | 22.78% |
| 1.36 | 0.33 | 0.24 | 1.84 | 1.55 | 1.78 | 0.26 | 0.29 | 0.22 | 0.23 | 0.26 | 0.12 | |
| Interest | 0.10 | 0.23 | 0.41 | 0.62 | 0.48 | 0.43 | 0.42 | 0.31 | 0.45 | 0.61 | 0.61 | 0.50 |
| Depreciation | 0.58 | 1.03 | 0.81 | 1.25 | 0.86 | 0.55 | 0.41 | 0.32 | 0.26 | 0.24 | 0.12 | 0.14 |
| Profit before tax | 0.29 | -4.21 | -1.46 | -0.68 | 0.02 | 1.11 | -0.27 | 2.29 | 2.55 | 0.87 | 1.02 | 1.20 |
| Tax % | 106.90% | -14.73% | 8.90% | -14.71% | -50.00% | 30.63% | 11.11% | 5.68% | 18.82% | 27.59% | 25.49% | 25.00% |
| -0.02 | -3.59 | -1.60 | -0.58 | 0.03 | 0.77 | -0.30 | 2.17 | 2.07 | 0.63 | 0.75 | 0.89 | |
| EPS in Rs | -0.02 | -3.79 | -1.69 | -0.58 | 0.03 | 0.77 | -0.30 | 2.17 | 2.07 | 0.63 | 0.75 | 0.89 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 7% |
| 3 Years: | -13% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 38% |
| 3 Years: | -25% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 24% |
| 3 Years: | 9% |
| 1 Year: | 4% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.46 | 9.46 | 9.46 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 | 9.96 |
| Reserves | -12.65 | -16.24 | -17.83 | -17.93 | -18.09 | -17.33 | -17.63 | -15.52 | -13.43 | -12.79 | -12.02 | -11.15 |
| 0.34 | 1.44 | 4.69 | 5.08 | 4.75 | 4.48 | 4.34 | 3.27 | 5.75 | 5.75 | 5.00 | 5.00 | |
| 9.93 | 10.58 | 12.12 | 9.24 | 8.28 | 7.09 | 7.35 | 6.93 | 4.40 | 3.41 | 3.08 | 2.82 | |
| Total Liabilities | 7.08 | 5.24 | 8.44 | 6.35 | 4.90 | 4.20 | 4.02 | 4.64 | 6.68 | 6.33 | 6.02 | 6.63 |
| 4.28 | 1.07 | 4.33 | 3.22 | 1.84 | 1.44 | 1.03 | 0.90 | 0.80 | 0.95 | 1.02 | 1.32 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.88 | 0.94 | 1.15 | 1.29 | 1.27 | 1.27 | 1.27 | 2.97 | 2.97 | 2.97 | 2.97 |
| 2.80 | 3.29 | 3.17 | 1.98 | 1.77 | 1.49 | 1.72 | 2.47 | 2.91 | 2.41 | 2.03 | 2.34 | |
| Total Assets | 7.08 | 5.24 | 8.44 | 6.35 | 4.90 | 4.20 | 4.02 | 4.64 | 6.68 | 6.33 | 6.02 | 6.63 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.70 | -0.19 | 1.76 | -0.69 | 0.36 | 0.52 | 0.42 | 1.51 | 1.13 | 1.18 | 1.51 | 1.37 | |
| 1.04 | -1.29 | -4.17 | -0.31 | 0.23 | -0.13 | -0.14 | -0.11 | -1.84 | -0.34 | -0.18 | -0.47 | |
| -2.76 | 1.46 | 2.48 | 0.97 | -0.56 | -0.43 | -0.27 | -1.15 | 0.94 | -0.78 | -1.32 | -0.63 | |
| Net Cash Flow | -0.02 | -0.01 | 0.06 | -0.03 | 0.02 | -0.04 | 0.01 | 0.25 | 0.24 | 0.06 | 0.00 | 0.27 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 31.97 | 37.54 | 26.60 | 18.22 | 9.29 | 21.66 | 20.61 | 24.83 | 15.86 | 31.51 | 17.36 | 23.21 |
| Inventory Days | 32.28 | 86.45 | 56.15 | 29.80 | 20.77 | 87.60 | ||||||
| Days Payable | 369.97 | 1,349.54 | 1,644.51 | 1,512.14 | 1,261.18 | 1,686.30 | ||||||
| Cash Conversion Cycle | -305.72 | -1,225.55 | -1,561.75 | -1,464.13 | -1,231.12 | 21.66 | 20.61 | 24.83 | 15.86 | 31.51 | 17.36 | -1,575.49 |
| Working Capital Days | -255.77 | -411.41 | -570.42 | -510.15 | -402.16 | -351.46 | -459.41 | -181.86 | -106.55 | -107.24 | -108.37 | -96.21 |
| ROCE % | -17.30% | 56.92% | 55.63% | 50.45% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 5 May
-
Results - For FY 2024-25
3 May - Audited FY25 financial results approved; Scheme of Amalgamation with Vijaya Diagnostic Centre pending NCLT approval.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
28 Apr - Shareholders approved Scheme of Amalgamation between Medinova Diagnostic and Vijaya Diagnostic.
-
Board Meeting Intimation for Approval Of Audited Financial Results Of The Company
26 Apr - Board meeting on May 3 to approve FY25 results; trading window closed April 1 to May 5.
-
Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting
25 Apr - Shareholders approved Medinova's amalgamation with Vijaya Diagnostic Centre via NCLT meeting on April 25, 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Services Offered:[1]
Company has four centers situated at Hyderabad, Pune and Kolkata which offers services ranging from an blood test to a CT/MRI Scan. Investigations are broadly classified as Lab, Pathological, Radiology, Imageology, Cardiology and Gastroscopy. Other services include:
a) Master Health Check Up
b) Executive Health Check Up
c) Well Woman Check Up
d) Cardiac Profile
e) Diabetic Profile
f) Corporate Services
g) Home visits
h) Ambulance Services
i) Health Camps
Company is also expanding its services to Executives, Government Employees, Industrial workers etc., through various tie-ups.